Market Size of India Insulin Infusion Pump Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Historical Data Period | 2019 - 2022 |
CAGR | > 3.00 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
India Insulin Infusion Pump Market Analysis
India's Insulin Infusion Pumps Market is expected to register a CAGR of more than 3% and reach a value of about USD 23 million over the forecast period.
Diabetes was a significant risk factor for a severe COVID-19 course. Several diabetes-related factors, including advanced age, hyperglycemia, and underlying diseases (hypertension, cardiovascular disease, chronic renal disease, and obesity), were believed to impact this risk. During the COVID-19 pandemic, diabetes was soon identified as a risk factor for unfavorable outcomes, making diabetes control or delay more critical than ever.
Diabetes mellitus, or diabetes in general, is defined by high blood glucose levels. Type 1 diabetes is caused by a total absence of insulin, often known as insulin-dependent diabetes mellitus. Type 2 diabetes mellitus is a disorder in which the body either does not create enough insulin or is unable to use the insulin that it does make. Diabetes type 2 is classified as a disease of lifestyle. Sugary treats, as well as historical practices and religious events, are an important component of Indian culture. According to an article published in "THE HINDU," India accounts for one out of every six diabetes globally. Data show that the country has an estimated 80 million diabetics, placing it second in the world. Diabetes affects over half of all Indians at some point in their lives, making it a major public health problem. Type 2 diabetes is becoming more common in rural India. This drives the market forward and accelerates the adoption of new and advanced technologies.
An insulin infusion pump is an alternative to the usual approach of daily injections or an insulin pen. Insulin infusion pumps prevent significant fluctuations in blood glucose levels, reduce discomfort, and provide insulin more precisely than injections. When employing pumps, meal timings are not necessary. This makes infusion pumps more user-friendly for patients. Insulin treatment is also known as continuous subcutaneous insulin infusion (CSII). It is an effective and versatile insulin delivery technique. The insulin pump has progressed and is now more dependable than it was previously. CSII technology has seen several technical breakthroughs, including the integration of continuous glucose monitoring with the pump. Insulin pumps may now regulate the algorithm that automatically delivers insulin after analyzing the blood glucose data.
India Insulin Infusion Pump Industry Segmentation
An insulin pump is used to deliver insulin to achieve proper blood sugar control and minimize hypoglycemia's effects. The pump is composed of a pump reservoir like an insulin cartridge, a battery-operated pump, and a computer chip that allows the user to control the exact amount of insulin being delivered. The pump is attached to a thin plastic tube (an infusion set) with a soft cannula (or needle) at the end through which insulin passes. India's insulin infusion pumps market is segmented by component (pump device, infusion set, and reservoir). The report offers the value (in USD million) and Volume (in units Million) for the above segments.
Insulin Infusion Pump | |
Insulin Pump Device | |
Infusion Set | |
Reservoir |
India Insulin Infusion Pump Market Size Summary
The insulin infusion pump market in India is poised for growth, driven by the increasing prevalence of diabetes and the adoption of advanced medical technologies. Diabetes, a major public health concern in India, affects a significant portion of the population, with lifestyle factors and cultural practices contributing to its rise, particularly type 2 diabetes in rural areas. Insulin infusion pumps offer a more precise and user-friendly alternative to traditional insulin delivery methods, such as injections, by preventing significant fluctuations in blood glucose levels and reducing discomfort. The integration of continuous glucose monitoring with insulin pumps has further enhanced their reliability and effectiveness, making them a preferred choice for managing diabetes, especially type 1 diabetes. This technological advancement is expected to propel the market forward, as more patients and healthcare providers recognize the benefits of continuous subcutaneous insulin infusion systems.
The market landscape is characterized by a concentration of a few major players, both globally and locally, such as Medtronic PLC, Insulet Corporation, Ypsomed, Ascensia Diabetes Care, and Tandem Diabetes Care. These companies are actively involved in introducing innovative products to meet the growing demand for diabetes management solutions. The increasing incidence of obesity and hereditary risks associated with type 2 diabetes, along with the rising number of type 1 diabetes patients, are key factors driving market expansion. Additionally, digital health technologies and applications that support diabetes self-management are enhancing patient care and improving health outcomes, thereby creating favorable market prospects. The competitive environment is marked by strategic initiatives, such as product launches and collaborations, aimed at strengthening market presence and addressing the evolving needs of diabetic patients in India.
India Insulin Infusion Pump Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.3 Market Restraints
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products and Services
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 Insulin Infusion Pump
-
2.1.1 Insulin Pump Device
-
2.1.2 Infusion Set
-
2.1.3 Reservoir
-
-
India Insulin Infusion Pump Market Size FAQs
What is the current India Insulin Infusion Pump Market size?
The India Insulin Infusion Pump Market is projected to register a CAGR of greater than 3% during the forecast period (2024-2029)
Who are the key players in India Insulin Infusion Pump Market?
Medtronic, Ascensia Diabetes Care, Insulet Corporation, Tandem Diabetes Care and Ypsomed are the major companies operating in the India Insulin Infusion Pump Market.